ACTINOGEN MEDICAL LIMITED

Press Releases Actinogen Medical Limited

Equities

ACW

AU000000ACW3

Delayed Australian S.E. Other stock markets 01:37:11 2024-04-29 am EDT			5-day change	1st Jan Change
0.031 ^AUD	+3.33%		+3.33%	+40.91%

Apr. 22	Actinogen Medical Limited Announces the Full Enrolment of 167 Participants in the Company's XanaCIDD Phase 2A Clinical Trial in Patients with Cognitive Importive in Major Depressant Disorder	CI
Apr. 22	Actinogen Medical Completes Patient Enrolment for XanaCIDD Phase 2a Trial; Shares Up 3%	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Actinogen Medical : ACW CEO presentation to Spark Plus Aust Equities Day	22-07-27	PU
Actinogen Medical : Application for quotation of securities - ACW	22-07-14	PU
Actinogen Medical : Application for quotation of securities - ACW	22-05-24	PU
Actinogen Medical : Quarterly Activity Report & Appendix 4C	22-04-27	PU
Actinogen Medical : ACW positive XanaMIA results webcast slide presentation	22-04-26	PU
Actinogen Medical : Application for quotation of securities - ACW	22-04-05	PU
Actinogen Medical : Letter to Shareholders & Notice of General Meeting	22-03-01	PU
Actinogen Medical : ACW CEO Presents at European Life Sciences Conference	22-02-28	PU
Actinogen Medical : Appendix 4D & Half-Year Financial Statements	22-02-23	PU
Actinogen Medical : Application for quotation of securities - ACW	22-01-13	PU
Actinogen Medical : ACW CEO Presents at San Francisco Healthcare Conference	22-01-09	PU
Actinogen Medical : Application for quotation of securities - ACW	21-12-19	PU
Actinogen Medical : Share Purchase Plan Offer Booklet	21-11-28	PU
Actinogen Medical : Proposed issue of securities - ACW	21-11-24	PU
AGM Presentations	21-11-09	PU
Actinogen Medical : ACW 2019 AGM Chairman's Address	19-11-24	PU
Cognitive Improvement Demonstrated With Xanamem™: Actinogen Medical	19-09-30	BU
Actinogen Medical : Final Patient Enrolled in Landmark Alzheimer’s Treatment Trial Targeting Stress Hormone Cortisol	18-11-25	BU
Actinogen Medical : Announces Landmark Research on Excess Cortisol and Alzheimer’s Disease	16-07-27	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer